Clopidogrel

Major

Clopidogrel Morphine Injection Astramorph® PF Reduced efficacy of clopidogrel Details Clopidogrel Nalbuphine Injection Nubain® Reduced efficacy of clopidogrel Details

Moderate

Clopidogrel Simvastatin Flolipid Decreased formation of clopidogrel active metabolite resulting in high on-treatment platelet reactivity Details Clopidogrel Asciminib Scemblix Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Atorvastatin Atorvaliq Decreased formation of clopidogrel active metabolite resulting in high on-treatment platelet reactivity Details Clopidogrel Capsaicin Arthricare for Women Moisturizing Increased risk of bleeding Details Clopidogrel Capsaicin Topical Aspercreme Warming® Increased risk of bleeding Details Clopidogrel Capsaicin Transdermal Patch Aspercreme Warming® Patch Increased risk of bleeding Details Clopidogrel Chloramphenicol Injection Chloromycetin® Injection Reduction in clinical efficacy of clopidogrel Details Clopidogrel Angelica Increased risk of bleeding Details Clopidogrel Anise Increased risk of bleeding Details Clopidogrel Armodafinil Nuvigil Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Astragalus Increased risk of bleeding Details Clopidogrel Asunaprevir Increased clopidogrel active metabolite exposure and an increased platelet inhibition Details Clopidogrel Berotralstat Orladeyo Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Bilberry Increased risk of bleeding Details Clopidogrel Black Currant Increased risk of bleeding Details Clopidogrel Bladderwrack Increased risk of bleeding Details Clopidogrel Bogbean Increased risk of bleeding Details Clopidogrel Boldo Increased risk of bleeding Details Clopidogrel Borage Increased risk of bleeding Details Clopidogrel Cannabidiol Epidiolex Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Cannabis Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Cat's Claw Increased risk of bleeding Details Clopidogrel Cenobamate Xcopri Increased exposure to CYP2C19 substrates and/or increased risk of adverse effects Details Clopidogrel Chaparral Increased risk of bleeding Details Clopidogrel Chloramphenicol Reduction in clinical efficacy of clopidogrel Details Clopidogrel Cimetidine Tagamet Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Clove Oil Increased risk of bleeding Details Clopidogrel Dandelion Increased risk of bleeding Details Clopidogrel Desogestrel Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Dexlansoprazole Dexilant Reduced antiplatelet activity Details Clopidogrel Dicloxacillin Increased clopidogrel active metabolite exposure and an increased platelet inhibition Details Clopidogrel Dienogest Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Donanemab-Azbt An increased risk of amyloid related imaging abnormalities (ARIA), or intracerebral hemorrhage Details Clopidogrel Drospirenone Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Efavirenz Altered clopidogrel active metabolite exposure and altered platelet inhibition and an increased risk of bleeding Details Clopidogrel Elagolix Orilissa Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Enasidenib Idhifa Reduced clopidogrel active metabolite exposure and reduced platelet inhibition Details Clopidogrel Enzalutamide Xtandi Increased clopidogrel active metabolite exposure and an increased platelet inhibition Details